There is an increasing body of evidence showing that depression and anxiety are linked with other health conditions like cancer and cardiovascular disease. I’ve blogged about the link between depression and stroke, and there are a number of other studies that show an association between psychological distress (the symptoms of depression and anxiety) and mortality, [read the full story…]
Back in February, I blogged about a cohort study published in the New England Journal of Medicine, which concluded that ADHD drugs are not linked with an increased risk of serious cardiovascular events. The last few years has seen heated debate about the use of central nervous stimulants in children and young people. The lack [read the full story…]
NICE published a clinical guideline on the treatment and management of depression in adults with chronic physical health problems in 2009. This new evidence update refreshes that guidance by searching for new systematic reviews and randomised controlled trials on the subject and summarising them in a short (16 page) document. The authors searched a range [read the full story…]
A number of concerns have arisen over recent years about the safety of the various drugs used to treat ADHD (Attention Deficit Hyperactivity Disorder) in children and young adults. These central nervous system stimulants include methylphenidate, dexmethylphenidate, dextroamphetamines, amphetamine salts, atomoxetine and pemoline. Case reports have highlighted that sudden cardiac death can be brought on [read the full story…]
Read this important new research if you work in mental health or public health and have an interest in the relationship between mental disorders and adversity in childhood and chronic physical conditions in later adult life. The cross sectional study was conducted by researchers in New Zealand who set out to investigate whether childhood adversities [read the full story…]
We know from epidemiological studies that people with schizophrenia are 2-3 times more likely to smoke than the rest of the population. We also know that schizophrenia is associated with a higher risk of coronary heart disease. This retrospective cohort study carried out by researchers from the University of Maryland set out to explore the impact [read the full story…]
This cohort study conducted by researchers from the St. Louis Veterans Affairs Medical Center set out to answer the question: Are antidepressants associated with an increased or decreased risk of incident myocardial infarction and all-cause mortality? 93,653 patients aged 25–80 years (average age 51.5 years, 14.1% female, 77.8% White, 57.1% not married) were identified using the [read the full story…]
A new meta-analysis published in the British Journal of Psychiatry has found that people with mental health problems are significantly less likely to receive important cardiac treatment (revascularisation, angiography, angioplasty and bypass grafting) following a cardiac event. People with mental illness experience a 14% lower rate of invasive coronary interventions following a cardiac event and [read the full story…]
Patients with coronary heart disease are susceptible to depression and this comorbidity makes cardiovascular outcomes worse. Using antidepressants to treat depression in patients with other health conditions is sometimes quite controversial. This meta-analysis looked at the health effects of selective serotonin reuptake inhibitors (SSRIs) versus placebo or no antidepressants in patients with coronary heart disease [read the full story…]
